Holdings of Global X Genomics & Biotechnology ETF
GLOBAL X FUNDS
· 50 declared positions · as of Feb 28, 2026
Original filing · Net assets 52.4M $ · Ten largest lines: 49.8 % of the equity sleeve
Sector breakdown
- Health care 33.7 %
- Unattributed 66.3 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 96.3 %
- GBP 2.3 %
- HKD 1.5 %
The quoted currency of each line, as declared.
Country breakdown
- US 84.5 %
- DE 3.9 %
- CH 3.5 %
- GB 2.3 %
- KY 2.1 %
- SG 1.5 %
- HK 1.5 %
- NL 0.7 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|
| US | 43 | 44.3M $ | 84.55 % |
| DE | 1 | 2M $ | 3.87 % |
| CH | 1 | 1.8M $ | 3.48 % |
| GB | 1 | 1.2M $ | 2.28 % |
| KY | 1 | 1.1M $ | 2.14 % |
| SG | 1 | 786.3K $ | 1.50 % |
| HK | 1 | 761.6K $ | 1.45 % |
| NL | 1 | 378.9K $ | 0.72 % |
Positions
| Company | Shares | Value | Weight |
|---|
| Moderna Inc | 76,841 | 4.1M $ | 7.86 % |
| Praxis Precision Medicines Inc | 9,697 | 3.3M $ | 6.23 % |
| Arrowhead Pharmaceuticals Inc | 47,107 | 3M $ | 5.69 % |
| Illumina Inc | 19,973 | 2.7M $ | 5.13 % |
| Guardant Health Inc | 26,261 | 2.5M $ | 4.71 % |
| Vertex Pharmaceuticals Inc | 4,551 | 2.3M $ | 4.32 % |
| BioMarin Pharmaceutical Inc | 36,598 | 2.3M $ | 4.31 % |
| Natera Inc | 9,843 | 2M $ | 3.91 % |
| BioNTech SE | 18,367 | 2M $ | 3.87 % |
| AVIDITY BIOSCIENCES INC | 27,249 | 2M $ | 3.75 % |
| QIAGEN NV | 38,211 | 1.9M $ | 3.63 % |
| CRISPR Therapeutics AG | 30,338 | 1.8M $ | 3.48 % |
| Bio-Techne Corp | 30,603 | 1.8M $ | 3.45 % |
| Bristol-Myers Squibb Co | 22,278 | 1.4M $ | 2.65 % |
| Alnylam Pharmaceuticals Inc | 3,941 | 1.3M $ | 2.51 % |
| Veracyte Inc | 34,212 | 1.3M $ | 2.39 % |
| Eli Lilly & Co | 1,165 | 1.2M $ | 2.34 % |
| Twist Bioscience Corp | 25,637 | 1.2M $ | 2.30 % |
| Gilead Sciences Inc | 8,009 | 1.2M $ | 2.28 % |
| AstraZeneca PLC | 5,706 | 1.2M $ | 2.28 % |
| Beam Therapeutics Inc | 40,627 | 1.2M $ | 2.21 % |
| 10X Genomics Inc | 49,124 | 1.1M $ | 2.16 % |
| LEGEND BIOTECH CORP | 59,071 | 1.1M $ | 2.14 % |
| Ultragenyx Pharmaceutical Inc | 39,779 | 930.4K $ | 1.78 % |
| GeneDx Holdings Corp | 11,270 | 898.3K $ | 1.72 % |
| WaVe Life Sciences Ltd | 56,445 | 786.3K $ | 1.50 % |
| Genscript Biotech Corp | 498,918 | 761.6K $ | 1.45 % |
| Sarepta Therapeutics Inc | 40,976 | 686.8K $ | 1.31 % |
| Intellia Therapeutics Inc | 45,069 | 621.1K $ | 1.19 % |
| CareDx Inc | 22,308 | 418.5K $ | 0.80 % |
| uniQure NV | 24,242 | 378.9K $ | 0.72 % |
| Vir Biotechnology Inc | 40,138 | 364.9K $ | 0.70 % |
| Personalis Inc | 23,562 | 213.5K $ | 0.41 % |
| Pacific Biosciences of California Inc | 119,496 | 200.8K $ | 0.38 % |
| Agilent Technologies Inc | 1,653 | 200.6K $ | 0.38 % |
| Rocket Pharmaceuticals Inc | 37,567 | 188.2K $ | 0.36 % |
| Prime Medicine Inc | 40,671 | 187.9K $ | 0.36 % |
| REGENXBIO Inc | 20,483 | 185.2K $ | 0.35 % |
| Myriad Genetics Inc | 39,242 | 180.9K $ | 0.35 % |
| Mesa Laboratories Inc | 1,851 | 178.8K $ | 0.34 % |
| Maravai LifeSciences Holdings Inc | 46,674 | 166.2K $ | 0.32 % |
| Stoke Therapeutics Inc | 4,522 | 164.6K $ | 0.31 % |
| Standard BioTools Inc | 119,323 | 134.8K $ | 0.26 % |
| Fulgent Genetics Inc | 8,763 | 134.3K $ | 0.26 % |
| Arcturus Therapeutics Holdings Inc | 15,040 | 123.8K $ | 0.24 % |
| Caribou Biosciences Inc | 59,913 | 113.8K $ | 0.22 % |
| Sana Biotechnology Inc | 26,441 | 111.3K $ | 0.21 % |
| Sangamo Therapeutics Inc | 244,820 | 105.8K $ | 0.20 % |
| Editas Medicine Inc | 46,709 | 102.8K $ | 0.20 % |
| Atrium Therapeutics Inc | 2,725 | 40.2K $ | 0.08 % |